Single Arm Romiplostim to Prevent CIT

Clinical trial NCT07048249 · RECRUITING

Trial details

NCT number: NCT07048249
Sponsor: Children's Hospital Medical Center, Cincinnati
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Ewings Sarcoma Chemotherapy Induced Thrombocytopenia

Start date: 2024-01-26
Primary completion: 2027-01-01
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.